JP MORGAN/CALL/MCKESSON/650/0.01/17.01.25 | Real-time Bid/Ask 11:28:05 2024-05-23 EDT | ||
| 0.19 EUR / 0.2 EUR | +14.71% |
|
| Current month | -5.56% | ||
| 3 months | +21.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MCKESSON CORPORATION
Latest news about MCKESSON CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 0.18 | +5.88% |
| 24-05-22 | 0.17 | -19.05% |
| 24-05-21 | 0.21 | +5.00% |
| 24-05-20 | 0.2 | +5.26% |
| 24-05-17 | 0.19 | +5.56% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 04:38 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MCKESSON CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK2EYR |
| ISIN | DE000JK2EYR8 |
| Date issued | 2024-02-08 |
| Strike | 650 $ |
| Maturity | 2025-01-17 (239 Days) |
| Parity | 100 : 1 |
| Emission price | 0.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.23 € |
|---|---|
| Lowest since issue | 0.11 € |
| Spread | 0.01 € |
| Spread % | 4.76% |
Company Profile
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
-
Consensus: McKesson Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
557.4
USD
Average target price
584.1
USD
Spread / Average Target
+4.79%
- Stock Market
- Warrants
- Warrant
